New injectable HIV prevention program aims to protect latine communities
NCT ID NCT07218211
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a long-acting injectable PrEP (lenacapavir) program designed specifically for Latine gay, bisexual men and transgender women. Researchers want to see if offering the shots at community organizations helps more people stay on HIV prevention compared to standard clinic care. The study involves 100 HIV-negative participants in the southern U.S. and focuses on identifying barriers and facilitators to PrEP use.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
lenacapavir (long-acting injectable PrEP)
What this could lead to
If successful, this program could make it easier for Latine gay, bisexual men and transgender women to stay on HIV prevention, reducing new infections in these communities.
What could go wrong
This is a small, early-phase study (100 participants) comparing to historical data, not a randomized trial. Results may not apply broadly, and long-term adherence remains uncertain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV PRE-EXPOSURE PROPHYLAXIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
El Centro Hispano
RECRUITINGDurham, North Carolina, 27701, United States
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••